Jurkunas U - Search Results

1

Vavvas DG, Dryja TP, Wilson ME, Olsen TW, Shah A, Jurkunas U, Pineda R, Poulaki V, Palioura S, Veldman P, Moreno-Montañés J, Pinazo-Duran MD, Pastor JC, Tsilimbaris M, Rhee D, Colby K, Hunter DG, Thanos S, Sakamoto T, Pasquale LR, Miller JW, VanderVeen D, Lambert SR. Vavvas DG, et al. Among authors: jurkunas u. Nature. 2018 Apr 4;556(7699):E2-E3. doi: 10.1038/nature26149. Nature. 2018. PMID: 29620729 No abstract available.

2

Use of voriconazole in the treatment of fungal keratitis.

Jurkunas UV, Langston DP, Colby K. Jurkunas UV, et al. Int Ophthalmol Clin. 2007 Spring;47(2):47-59. doi: 10.1097/IIO.0b013e318036bd47. Int Ophthalmol Clin. 2007. PMID: 17450006 Review. No abstract available.

3

Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy.

Jurkunas UV, Rawe I, Bitar MS, Zhu C, Harris DL, Colby K, Joyce NC. Jurkunas UV, et al. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2956-63. doi: 10.1167/iovs.07-1529. Epub 2008 Mar 31. Invest Ophthalmol Vis Sci. 2008. PMID: 18378575 Free PMC article.

4

Increased clusterin expression in Fuchs' endothelial dystrophy.

Jurkunas UV, Bitar MS, Rawe I, Harris DL, Colby K, Joyce NC. Jurkunas UV, et al. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2946-55. doi: 10.1167/iovs.07-1405. Epub 2008 Mar 31. Invest Ophthalmol Vis Sci. 2008. PMID: 18378577 Free PMC article.

5

Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.

Dastjerdi MH, Al-Arfaj KM, Nallasamy N, Hamrah P, Jurkunas UV, Pineda R 2nd, Pavan-Langston D, Dana R. Dastjerdi MH, et al. Arch Ophthalmol. 2009 Apr;127(4):381-9. doi: 10.1001/archophthalmol.2009.18. Arch Ophthalmol. 2009. PMID: 19365012 Free PMC article. Clinical Trial.

6

Fungal keratitis: changing pathogens and risk factors.

Jurkunas U, Behlau I, Colby K. Jurkunas U, et al. Cornea. 2009 Jul;28(6):638-43. doi: 10.1097/ICO.0b013e318191695b. Cornea. 2009. PMID: 19512908

7

Intraocular lens calculations after corneal refractive surgery.

Mandell KJ, Jurkunas UV, Pineda R 2nd. Mandell KJ, et al. Int Ophthalmol Clin. 2010 Winter;50(1):181-9. doi: 10.1097/IIO.0b013e3181c5542f. Int Ophthalmol Clin. 2010. PMID: 20057306 Review. No abstract available.

8

Predictive Factors for Corneal Clearance After Descemetorhexis Without Endothelial Keratoplasty.

Davies E, Jurkunas U, Pineda R 2nd. Davies E, et al. Among authors: jurkunas u. Cornea. 2018 Feb;37(2):137-140. doi: 10.1097/ICO.0000000000001427. Cornea. 2018. PMID: 29053562

9

Exposure, entropion, and bilateral corneal ulceration in a newborn as a manifestation of chromosome 22 q11.2 duplication syndrome.

Moein HR, Saeed HN, Jacobs DS, Rapoport Y, Yoon MK, Shah AS, Khan H, Raoof D, Jurkunas UV. Moein HR, et al. Am J Ophthalmol Case Rep. 2018 Nov 4;13:16-19. doi: 10.1016/j.ajoc.2018.11.001. eCollection 2019 Mar. Am J Ophthalmol Case Rep. 2018. PMID: 30505980 Free PMC article.

10

Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.

Davies E, Jurkunas U, Pineda R 2nd. Davies E, et al. Among authors: jurkunas u. Cornea. 2021 Jul 1;40(7):899-902. doi: 10.1097/ICO.0000000000002691. Cornea. 2021. PMID: 33758139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page